유리화 시장 : 제품 유형별, 용도별, 최종사용자별, 지역별

The global vitrification market is estimated to be valued at USD 9.30 Bn in 2024 and is expected to reach USD 26.51 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 16.1% from 2024 to 2031.

Figure. Vitrification Market Share (%), By Region 2024

The global vitrification market is witnessing a steady growth owing to rising demand for assisted reproductive technologies (ART) across the globe. Vitrification is an advanced cooling technique used for cryopreservation of human eggs, embryos, and ovarian tissue during IVF procedures. This process involves extremely rapid cooling of biological samples to glassy solidity without any ice crystal formation, thereby preserving viability. With rising infertility rates, expanding base of medical tourism for fertility treatments, and improving success rates of vitrified IVF cycles compared to conventional slow freezing techniques, the global vitrification market is estimated to grow at a significant pace over the next decade.

Market Dynamics:

The global vitrification market is driven by rising prevalence of infertility worldwide. In April 2023, according to WHO, around 48 million couples globally suffered from infertility issues. Additionally, delaying parenthood, increasing stress levels, obesity, sexually transmitted diseases, and other lifestyle factors are contributing to higher infertility rates. For instance, yn February 2022, according to the National Library of Medicine, 15 European nations provide full or partial coverage of IVF cycles under public health insurance. However, high cost of vitrification procedure, ethical concerns regarding cryopreservation of human tissues, and lack of awareness in developing regions are some of the factors restricting broader adoption of this technology. Moreover, stringent regulations for health facilities providing fertility treatments pose challenges for market players. With ongoing R&D focusing on developing more efficient vitrification solutions, the market is expected to witness lucrative opportunities. Market leaders are investing in technologies such as open versus closed vitrification systems and better cryoprotectants to improve success rates of vitrified cycles. Increasing medical tourism in low-cost countries and rising disposable income in developing nations will further support the demand for ART in the coming years.

Key Features of the Study:

This report provides in-depth analysis of the global vitrification market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global vitrification market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Vitrolife AB, CooperSurgical, Inc., Merck KGaA, Ferring Pharmaceuticals, Igenomix, Genea Biomedx, Cryoport, Inc., Kitazato Corporation, ReproTech, LLC, Thermo Fisher Scientific, EMD Serono, OvaScience, Inc., LifeGlobal, Medline Industries, Inc., and Reproductive Health Technologies

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global vitrification market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vitrification market

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2019 - 2031)
  • Vitrification Solutions
  • Vitrification Equipment
  • Other Related Products
• Application Insights (Revenue, USD Bn, 2019 - 2031)
  • In Vitro Fertilization (IVF)
  • Stem Cell Preservation
  • Other Applications
• End User Insights (Revenue, USD Bn, 2019 - 2031)
  • Fertility Clinics
  • Hospitals and Diagnostic Centers
  • Research Institutes
  • Biobanks
  • Others
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Key Players Insights
  • Vitrolife AB
  • CooperSurgical, Inc.
  • Merck KGaA
  • Ferring Pharmaceuticals
  • Igenomix
  • Genea Biomedx
  • Cryoport, Inc.
  • Kitazato Corporation
  • ReproTech, LLC
  • Thermo Fisher Scientific
  • EMD Serono
  • OvaScience, Inc.
  • LifeGlobal
  • Medline Industries, Inc.
  • Reproductive Health Technologies

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Vitrification Market, By Product Type
  • Global Vitrification Market, By Application
  • Global Vitrification Market, By End User
  • Global Vitrification Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Vitrification Market, By Product Type, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Vitrification Solutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Vitrification Equipment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Other Related Products
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Vitrification Market, By Application, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• In Vitro Fertilization (IVF)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Stem Cell Preservation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Other Applications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Vitrification Market, By End User, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Fertility Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Hospitals and Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Biobanks
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Vitrification Market, By Region, 2019 - 2031, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Vitrolife AB
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• CooperSurgical, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ferring Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Igenomix
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Genea Biomedx
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cryoport, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Kitazato Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• ReproTech, LLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• EMD Serono
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• OvaScience, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• LifeGlobal
• Medline Industries, Inc.
• Reproductive Health Technologies

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us